Gordon syndrome and succinylcholine.

J Inherit Metab Dis

District Hospital of Valkeakoski, Medical Center Mehiläinen, Tampere, Finland.

Published: July 2006

We present a case of 6-year-old boy who developed severe hyperkalaemia and ventricular tachycardia after administration of succinylcholine. Ventricular tachycardia was defibrillated and Gordon syndrome, which was diagnosed subsequently, was treated successfully. Paediatric patients with underlying metabolic disorders such as Gordon syndrome are at high risk of developing severe hyperkalaemia after succinylcholine administration.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-005-0165-zDOI Listing

Publication Analysis

Top Keywords

gordon syndrome
12
severe hyperkalaemia
8
ventricular tachycardia
8
syndrome succinylcholine
4
succinylcholine case
4
case 6-year-old
4
6-year-old boy
4
boy developed
4
developed severe
4
hyperkalaemia ventricular
4

Similar Publications

Hypertension is a growing concern worldwide, with increasing prevalence rates in both children and adults. Most cases of hypertension are multifactorial, with various genetic, environmental, socioeconomic, and lifestyle influences. However, monogenic hypertension, a blanket term for a group of rare of hypertensive disorders, is caused by single-gene mutations that are typically inherited in an autosomal dominant fashion, and ultimately disrupt normal blood pressure regulation in the kidney or adrenal gland.

View Article and Find Full Text PDF

Gordon syndrome (GS), also known as distal arthrogryposis type 3, is a rare congenital disorder characterized by debilitating multisystem defects and for which there is currently no cure. In the absence of a definitive treatment, multimodal symptomatic approaches are employed to enhance quality of life. The case presented involves a 40-year-old female with GS who exhibited multiple chronic, widespread, and severe musculoskeletal ailments that limited her daily functional capacity.

View Article and Find Full Text PDF

Pseudohypoaldosteronism type II and sensory neuropathy associated with a heterozygous pathogenic variant in KLHL3 gene, a case report.

Heliyon

November 2024

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience and Cognition, F-59000, Lille, France.

Pseudohypoaldosteronism type II is a rare Mendelian disorder characterized by hypertension, hyperkalemia, hyperchloremia and metabolic acidosis, despite a normal glomerular filtration rate. Four genes (, , and ) are associated with this disease. Mutations in the gene cause pseudohypoaldosteronism type II in either an autosomal dominant or a recessive inheritance pattern.

View Article and Find Full Text PDF

Pseudohypoaldosteronism type 2 (PHA2) is a rare inherited condition of altered tubular salt handling. It is characterized by the specific constellation of hyperkalaemic hyporeninemic hypertension, hyperchloremic metabolic acidosis and hypercalciuria. Molecular genetic testing confirms the diagnosis in the majority of cases.

View Article and Find Full Text PDF

Background: The Ankyrin Repeat Domain Containing Protein 17 (, OMIM:615929) gene is a protein-coding gene associated with diseases such as Chopra-Amiel-Gordon Syndrome and Non-Specific Syndromic Intellectual Disability. The protein encoded by gene belongs to the ankyrin repeat-containing protein family, which is one of the most widely existing protein domains that exclusively mediate protein-protein interactions. To date, the research and reports on the gene are limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!